The online version of this article (https://doi.org/10.1007/s40121-019-0235-4) contains supplementary material, which is available to authorized users.
To view enhanced digital features for this article go to https://doi.org/10.6084/m9.figshare.7637267
Past endeavours to deal with the obstacle of expensive Cluster of Difference 4 (CD4+) count diagnostics in resource-limited settings have left a long trail of suggested continuous CD4+ count clinical covariates that turned out to be a potentially important integral part of the human immunodeficiency virus (HIV) treatment process during disease progression. However, an evaluation to determine the strongest candidates among these CD4+ count covariates has not been well documented.
The Centre for the AIDS Programme of Research in South Africa (CAPRISA) initially enrolled HIV-negative (phase 1) patients into different study cohorts. The patients who seroconverted (237) during follow-up care were enrolled again into a post-HIV infection cohort where they were further followed up with weekly to fortnightly visits up to 3 months (phase 2: acute infection), monthly visits from 3–12 months (phase 3: early infection) and quarterly visits thereafter (phase 4: established infection) until antiretroviral therapy (ART) initiation (phase 5). The CD4+ count and 46 covariates were repeatedly measured at each phase of the HIV disease progression. A multilevel partial least squares approach was applied as a variable reduction technique to determine the strongest CD4+ count covariates.
Only 18 of the 46 investigated clinical attributes were the strongest CD4+ count covariates and the top 8 were positively and independently associated with the CD4+ count. Besides the confirmatory lymphocytes, these were basophils, albumin, haematocrit, alkaline phosphatase (ALP), mean corpuscular volume (MCV), platelets, potassium and monocytes. Overall, electrolytes, proteins and red blood cells were the dominant categories for the strongest covariates.
Only a few of the many previously suggested continuous CD4+ count clinical covariates showed the potential to become an important integral part of the treatment process. Prolonging the pre-treatment period of the HIV disease progression by effectively incorporating and managing the covariates for long-term influence on the CD4+ cell response has the potential to delay challenges associated with ART side effects.
Beare A, Stockinger H, Zola H, Nicholson I. The CD system of leukocyte surface molecules: monoclonal antibodies to human cell surface antigens. Current Protocols in Immunology. 2008;73(80):A.4A.1-A.4A.73.
Kwantwi LB, Tunu BK, Boateng D, Quansah DY. Body mass index, haemoglobin, and total lymphocyte count as a surrogate for CD4 count in resource limited settings. Journal of Biomarkers. 2017;Volume 2017, Article ID 790735
Alavi SM, Ahmadi F, Farhad M. Correlation between total lymphocyte count, hemoglobin, hematocrit and CD4 count in HIV/AIDS patients. Acta Medica Iranica. 2009;47(1):1–4.
Moolla Y, Moolla Z, Reddy T, Magula N. The use of readily available biomarkers to predict CD4 cell counts in HIV-infected individuals. South Afr Fam Pract. 2015;57(5):293–6. CrossRef
Manoto SL, Lugongolo M, Govender U, Mthunzi-Kufa P. Point of care diagnostics for HIV in resource limited settings: An Overview. MDPI 2018;54(3).
Elsa Z. Healthcare systems in Sub-Saharan Africa: focusing on community-based delivery (CBD) of health services and the development of local research institutes. United Nations Peace and Progress. 2016;3(1):44–9.
Jeffery A. The NHI proposal risking lives for no good reason. In: South African Institute of Race Relations, editor. South Africa: South African Institute of Race Relations; 2016.
Nditunze L, Makuza S, Amoroso CL, Odhiambo J, Ntakirutimana E, Cedro L, et al. Assessment of essential medicines stock-outs at health centers in Burera District in Northern Rwanda. Rwanda Journal Series F: Medicine and Health Sciences 2015;2(1). CrossRef
Chip Lab. Rapid, label-free CD4 testing using a smartphone compatible device. The Royal Society of Chemistry. 2017;17:2910–9.
CMA Media Inc. Inexpensive CD4 counting for the developing world. JAMC. 2005;175(3):478.
Yakubu T, Dedu VK, Bampoh PO. Factors affecting CD4 count response in HIV patients within 12 months of treatment: a case study of Tamale Teaching Hospital. American Journal of Medical and Biological Research. 2016;4(4):78–83.
Lawrence Erlbaum Associates. Continuous and discrete variables. Journal of Consumer Psychology. 2001;10(1&2):37–533.
Weston R, Marett B. HIV infection pathology and disease progression. Clinical Pharmacist. 2009;1:387.
Braconnier P, Delforge M, Garjau M, Wissing KM, De Wit S. Hyponatremia is a marker of disease severity in HIV-infected patients: a retrospective cohort study. BMC Infectious Diseases 2017;17:98.
Xu L, Ye H, Huang F, Yang Z, Zhu B, Xu Y, et al. Moderate/severe hyponatremia increases the risk of death among hospitalized Chinese human immunodeficiency virus/acquired immunodeficiency syndrome patients. PLoS ONE. 2014;9(10):1–9.
Gie Liem D, Miremadi F, Keast RSJ. Reducing sodium in foods: the effect on flavor. Nutrients. 2011;3:694–711. CrossRef
Pravina P, Sayaji D, Avinash M. Calcium and its role in human body. International Journal of Research in Pharmaceutical and Biomedical Sciences. 2013;4(2):659–68.
Butt AA, Michaels S, Greer D, Clark R, Kissinger P, Martin DH. Serum LDH level as a clue to the diagnosis of histoplasmosis. The AIDS Read. 2002;12(7).
Pralhadrao HS, Kant C, Phepale K, Mali MK, Raghunath. Role of serum albumin level compared to CD4+ cell count as a marker of immunosuppression in HIV infection. Indian Journal of Basic and Applied Medical Research. 2016;5(3):495-502.
Fleischbeina E, O’Brienb J, Martelinoc R, Fenstersheibd M. Elevated alkaline phosphatase with raltegravir in a treatment experienced HIV patient. AIDS. 2008;22(17):2401–7. CrossRef
Gomo E, Ndhlovu P, Vennervald B, Nyazema N, Friis H. Enumeration of CD4 and CD8 T-cells in HIV infection in Zimbabwe using a manual immunocytochemical method. Cent Afr J Med. 2001;47(3):64–70. PubMed
Shiferaw MB, Tulu KT, Zegeye AM, Wubante AA. Liver enzymes abnormalities among highly active antiretroviral therapy experienced and HAART naïve HIV-1 infected patients at Debre Tabor Hospital, Northwest Ethiopia: a comparative cross-sectional study. AIDS Research and Treatment. 2016;Volume 2016, Article ID 19854
Vanisri H, Vadiraja N. Association between Red blood cell parameters and immune status in HIV infected males. Indian Journal of Pathology and Oncology. 2016;3(4):684–9. CrossRef
Vanisri H, Vadiraja N. Relationship between red blood cell parameters and immune status in HIV infected females. Indian Journal of Pathology and Oncology. 2016;3(2):255–9. CrossRef
Leticia OI, Ugochukwu A, Ifeanyi OE, Andrew A, Ifeoma UE. The correlation of values of CD4 count, platelet, PT, APTT, fibrinogen and factor VIII concentrations among HIV positive patients in FMC Owerri. IOSR Journal of Dental and Medical Sciences (IOSR-JDMS). 2014;13(9 Ver II):94-101. CrossRef
Iffen TS, Efobi H, Usoro CAO, Udonwa NE. Lipid profile of HIV-positive patients attending university of Calabar Teaching Hospital, Calabar - Nigeria. World Journal of Medical Sciences. 2010;5(4):89–93.
Misra R, Chandra P, Riechman SE, Long DM, Shinde S, Pownall HJ, et al. Relationship of ethnicity and CD4 Count with glucose metabolism among HIV patients on highly-active antiretroviral therapy (HAART). BMC Endocrine Disorders 2013;13(13).
Dimala CA, Kadia BM, Kemah B-L, Tindong M, Choukem S-P. Association between CD4 cell count and blood pressure and its variation with body mass index categories in HIV-infected patients. International Journal of Hypertension. 2018; Volume 2018, Article ID 1691474.
Esposito FM, Coutsoudis A, Visser J, Kindra G. Changes in body composition and other anthropometric measures of female subjects on highly active antiretroviral therapy (HAART): a pilot study in Kwazulu-Natal, South Africa. The Southern African Journal of HIV Medicine. 2008:36–42.
Fofana KC. Correlation between nutritional indicators and low CD4 count (<200 cells>/mm3) among HIV positive adults in Kapiri, Zambia [Thesis]: Georgia State University; 2016.
Venter E, Gericke G, Bekker P. Nutritional status, quality of life and CD4 cell count of adults living with HIV/AIDS in the Ga-Rankuwa area (South Africa). South African Journal of Clinical Nutrition. 2009;22(3):124–9. CrossRef
Sun J, and Reddy, C.K. Big Data Analytics for Healthcare. SIAM International Conference on Data Mining; Austin, TX.2013.
Meintjes G, Moorhouse MA, Carmona S, Davies N, Dlamini S, van Vuuren C, et al. Adult antiretroviral therapy guidelines 2017. Southern African Journal of HIV Medicine. 2017;18(1):a776. CrossRef
Chen W-T, Shiu C-S, Yang JP, Simoni JM, Fredriksen-Goldsen kI, Szu-Hsien Lee T, et al. Side effects of antiretroviral therapy (ART) are associated with depression in Chinese individuals with HIV: a mixed methods study. AIDS & Clinical Research. 2013;4(6).
Lands L. A Practical Guide to HIV Drug Side Effects for People Living with HIV/AIDS. In: Pustil R, editor: The Canadian AIDS Treatment Information Exchange (CATIE); 2006.
Opiyo WO, Ng’wena AGM, Ofulla AVO. Liver function markers and associated serum electrolytes changes in HIV patients attending Patient Support Centre Of Jaramogi Oginga Odinga Teaching And Referral Hospital, Kisumu County, Kenya. East African Medical Journal. 2013;90(9):276-87.
Adhikari PMR, Chowta MN, Ramapuram JT, Rao SB, Udupa K, Acharya SD. Prevalence of vitamin B12 and folic acid deficiency in HIV-positive patients and its association with neuropsychiatric symptoms and immunological response. Indian Journal of Sexually Transmitted Diseases and AIDS. 2016;37(2):178–84. PubMedPubMedCentralCrossRef
Fasakin K, Omisakin C, Esan A, Adebara I, Owoseni I, Omoniyi D, et al. Total and CD4+ T-lymphocyte count correlation in newly diagnosed HIV patients in resource-limited setting. Journal of Medical Laboratory and Diagnosis. 2014;5(2):22–8. CrossRef
Sen. LCS, Vyas A, Sanghi LCS, Shanmuganandan CK, Gupta CR, Kapila BK, et al. Correlation of CD4+ T cell count with total lymphocyte count, haemoglobin and erythrocyte sedimentation rate levels in human immunodeficiency virus type-l disease. MJAFI 2011;67(1):15-20. CrossRef
Maitra S, Yan J. Principal component analysis and partial least squares: two dimension deduction techniques for regression. Casualty Actuarial Society Discussion Paper Program 2008. p. 79-90.
Papagno L, Spina CA, Marchant A, Salio M, Rufer N, Little S, et al. Immune activation and CD8+ T-cell differentiation towards senescence in HIV-1 infection. PLoS Biol. 2004;2(2):0173–185. CrossRef
Project Inform. Monitoring HIV Blood Work: A Complete Guide for Monitoring HIV. In: New York State Department of Health, editor. San Francisco, CA 94103 26212007.
James AG. Understanding Blood Tests. In: The James, editor. Cancer Hospital and Richard J. Solove Research Institute.2017.
National Institutes of Health Clinical Center. Understanding your complete blood count (CBC) and common blood deficiencies. In: National Institutes of Health Clinical Center, editor. Bethesda2015.
NAM. CD4, viral load & other tests. UK2012.
Min B, Brown MA, LeGros G. Understanding the roles of basophils: breaking dawn. The Journal of Cells, Molecules, Systems and Technologies. 2011;135:192–7.
The Johns Hopkins Lupus Center. Blood Chemistry Panel America2017 [Available from: https://www.hopkinslupus.org/lupus-tests/screening-laboratory-tests/blood-chemistry-panel/.
Patil R, Kamble P, Raghuwanshi U. Serum ALP & GGT levels in HIV positive latients. International Journal of Recent Trends in Science And Technology. 2013;5(3):155–7.
Arya SS, Kumar PK. Folate: sources, production and bioavailability. Agro Food Industry Hi Tech. 2012;23(4):23–7.
Dieticians of Canada. Food Sources of Folate. In: Canadian Nutrient File Health Department, editor. Canada: Dieticians of Canada; 2014.
Junqueira L, Carneiro J, Kelley R. Basic Histology. A Lange Medical Book. 7th ed: Appleton and Lange; 2006.
Jensen FB, Fago A, Weber RE. Hemoglobin structure and function. Fish Physiology. 1998;17:1–40. CrossRef
Wintrobe M, Greer J. Wintrobe’s Clinical Hematology. Philadelphia.: Lippincott Williams & Wilkins, ; 2009.
Arika W, Nyamai D, Musila M, Ngugi M, Njagi E. Hematological markers of in vivo toxicity. Journal of Hematology & Thromboembolic Diseases. 2016;4(2).
Spectrum. Total protein: Biuret Reagent: Egyptian Company for Biotechnology (S.A.E); 2007.
- An Evaluation to Determine the Strongest CD4 Count Covariates during HIV Disease Progression in Women in South Africa
Nigel J. Garrett
- Springer Healthcare
Neu im Fachgebiet Innere Medizin
Meistgelesene Bücher aus der Inneren Medizin
Mail Icon II